Improving glucose management:: Ten steps to get more patients with type 2 diabetes to glycaemic goal -: Recommendations from the Global Partnership for Effective Diabetes Management

被引:110
作者
Del Prato, S
Felton, AM
Munro, N
Nesto, R
Zimmet, P
Zinman, B
机构
[1] Univ Pisa, Dept Endocrinol & Metab, Sect Diabet, Osped Cisanello, I-56124 Pisa, Italy
[2] Federat European Nurses Diabet, London, England
[3] Primary Care Diabet Europe, Surrey, England
[4] Lahey Clin Fdn, Burlington, MA USA
[5] Int Diabet Inst, Caulfield, Australia
[6] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
关键词
glycaemic control; glycaemic targets; patient management; type; 2; diabetes;
D O I
10.1111/j.1742-1241.2005.00674.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite increasingly stringent clinical practice guidelines for glycaemic control, the implementation of recommendations has been disappointing, with over 60% of patients not reaching recommended glycaemic goals. As a result, current management of glycaemia falls significantly short of accepted treatment goals. The Global Partnership for Effective Diabetes Management has identified a number of major barriers that can prevent individuals from achieving their glycaemic targets. This article proposes 10 key practical recommendations to aid healthcare providers in overcoming these barriers and to enable a greater proportion of patients to achieve glycaemic goals. These include advice on targeting the underlying pathophysiology of type 2 diabetes, treating early and effectively with combination therapies, adopting a holistic, multidisciplinary approach and improving patient understanding of type 2 diabetes. Implementation of these recommendations should reduce the risk of diabetes-related complications, improve patient quality of life and impact more effectively on the increasing healthcare cost related to diabetes.
引用
收藏
页码:1345 / 1355
页数:11
相关论文
共 95 条
[11]  
Barnett A H, 2002, Curr Med Res Opin, V18 Suppl 1, ps31, DOI 10.1185/030079902125000219
[12]  
BECKNIELSEN H, 1988, IKKEINSULINKRAEVENDE
[13]   β-cell rejuvenation with thiazolidinediones [J].
Bell, DSH .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 :20-23
[14]   Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes [J].
Blonde, L ;
Ginsberg, BH ;
Horn, S ;
Hirsch, IB ;
James, B ;
Mulcahy, K ;
Nettles, A ;
Smout, R ;
Wright, H .
DIABETES CARE, 2002, 25 (01) :245-246
[15]   Type 2 diabetes in the young - The evolving epidemic [J].
Bloomgarden, ZT .
DIABETES CARE, 2004, 27 (04) :998-1010
[16]   Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control [J].
Bonora, E ;
Calcaterra, F ;
Lombardi, S ;
Bonfante, N ;
Formentini, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2001, 24 (12) :2023-2029
[17]   Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence [J].
Bonora, E ;
Muggeo, M .
DIABETOLOGIA, 2001, 44 (12) :2107-2114
[18]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[19]   Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus -: A meta-analysis of controlled clinical trials [J].
Boulé, NG ;
Haddad, E ;
Kenny, GP ;
Wells, GA ;
Sigal, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (10) :1218-1227
[20]  
Brown J, 2003, DIABETES, V52, pA61